(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 1.31% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.96%.
Quidelortho's revenue in 2026 is $2,674,200,000.On average, 5 Wall Street analysts forecast QDEL's revenue for 2026 to be $177,953,233,065, with the lowest QDEL revenue forecast at $169,449,880,117, and the highest QDEL revenue forecast at $184,125,021,495. On average, 5 Wall Street analysts forecast QDEL's revenue for 2027 to be $181,244,853,561, with the lowest QDEL revenue forecast at $172,330,048,051, and the highest QDEL revenue forecast at $188,102,396,261.
In 2028, QDEL is forecast to generate $191,942,620,173 in revenue, with the lowest revenue forecast at $180,079,071,302 and the highest revenue forecast at $206,412,035,270.